Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:activeDuring |
lutropin_alfa
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:chemicalFormula |
C112H165N37O33S
|
| gptkbp:clinicalTrials |
Phase III
|
| gptkbp:dosageForm |
solution for injection
|
| gptkbp:firstAppearance |
2004
|
| https://www.w3.org/2000/01/rdf-schema#label |
Luveris
|
| gptkbp:issuedBy |
injection
|
| gptkbp:mandates |
hypogonadotropic_hypogonadism
|
| gptkbp:marketedAs |
Merck Serono
|
| gptkbp:packaging |
vial
|
| gptkbp:route |
subcutaneous
|
| gptkbp:sideEffect |
headache
nausea injection site reactions ovarian hyperstimulation syndrome |
| gptkbp:storage |
refrigerated
|
| gptkbp:usedFor |
infertility treatment
|
| gptkbp:variant |
Follistim
|
| gptkbp:weight |
2460.4 g/mol
|